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Background: PPP2R2C encodes a gamma isoform of the regulatory subunit B55 subfamily consisting PP2A heterotrimeric
with A and C subunits. Currently, the precise functions of B55gamma in cancer are still under investigating. In this project,
we reported a novel function of B55gamma in the regulation of glucose metabolism in Glioma cells.
Methods: Western blot and immunoprecipitation were performed to determine protein expression and interaction. Cell
viability was measured by Typan Blue staining and direct cell counting using hematocytometer. siRNA technology was
used to down regulate protein expression.
Results: Glucose uptake and lactate product were suppressed by overexpression of B55gamma in Glioma cells. In addition,
cancer cells with larger amount of B55gamma showed higher survival advantages in response to glucose starvation
through the dephosphorylation of S6K. From proteomic analysis, we found B55gamma binds with and up regulates
SIK2 through the stabilization of SIK2 protein which is required for the B55gamma-mediated suppression of S6K
pathway. Knocking down of SIK2 in B55gamma over expressing cells recovered the phosphorylation of S6K.
Conclusion: In summary, our project will provide novel insight into the design and development of therapeutic
strategies to target the B55gamma-mediated glucose metabolism for the treatment of human brain tumor patients.
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The PP2A heterotrimeric protein phosphatase is a ubiqui-
tous and conserved serine/threonine phosphatase with
broad substrate specificity and diverse cellular functions
[1]. It is composed of one structural A, one catalytic C,
and one regulatory B subunit that associates with a variety
of substrates [2]. Among the targets of PP2A are proteins
of oncogenic signaling cascades, such as Raf [3], MEK [4],
and AKT [5]. This suggests that specific PP2A holoen-
zymes play a role in cellular proliferation and oncogenic* Correspondence: menglll@yahoo.cn; liu326121228@163.com
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unless otherwise stated.transformation [2]. The regulatory B subunit can modulate
the activity of the PP2A, by targeting a wide range of
PP2A substrates. Four unrelated families of B subunits
have identified to date: B/B55/PR55/PPP2R2, B0/B56/
PR61/PPP2R5, B/PR72/PPP2R3, and Striatin [6]. PPP2R2C
encodes a gamma isoform of the regulatory subunit B55
subfamily-B55 gamma. Currently, the precise functions
of B55gamma are still under investigating. It has been
reported that B55gamma was an inhibitor of c-Jun NH2-
terminal kinase (JNK) activation by UV irradiation [7].
Currently, the function of B55gamma in tumor progres-
sion has not been well studied yet. A recent paper claimed
that B55gamma might be a tumor suppressor gene in
prostate cancers, they reported the loss of B55gammais an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cancer growth, which was independent of AR-mediated
transcriptional programs [8].
The Warburg effect is the observation that most cancer
cells predominantly produce energy by a high rate of
glycolysis followed by lactic acid fermentation in the cyto-
sol, rather than by a comparatively low rate of glycolysis
followed by oxidation of pyruvate in mitochondria as in
most normal cells [9]. Mutations in oncogenes and tumor
suppressor genes are known to be responsible for malig-
nant transformation, and the Warburg effect is the result
of oncogenic stimulation and loss of tumor suppressor
genes that lead to a series of metabolic reprogramming,
such as the expression and/or translocation of glucose
transporters to the plasma membrane [9,10] and upregula-
tion or activation of glycolytic enzymes. So far, multiple
oncogenes or tumor suppressors have been reported to
participate into the regulatory pathways in cancer cells
glucose metabolism, such as AKT [11], PI3K [12], P53
[13], PP2A [14], src [15], Ras [16] and c-myc [17].
Salt-inducible kinase (SIK1–3) is a serine/threonine pro-
tein kinase which belongs to a family of AMP-activated
protein kinases (AMPKs) [18]. SIK2 has been shown to
function in the insulin-signaling pathway during adipocyte
differentiation and to modulate CREB-mediated gene ex-
pression in response to hormones and nutrients [19].
However, molecular mechanism underlying the regulation
of SIK2 kinase activity remains largely elusive.
In this study, we reported a novel function of B55gamma
in the regulation of glucose metabolism in Glioma cells.
Exogenous over expression of the B55gamma in Glioma
cells suppressed the cancer cell glucose uptake and lactate
product, indicating a putative tumor suppression role.
Glioma cells with larger amount of B55gamma showed
higher survival advantages in response to glucose deprivation
through the inhibition of S6K pathway. Furthermore,
from proteomic analysis, we found B55gamma binds with
SIK2 and increases SIK2 stability in Glioma cells which
is required in the B55gamma-mediated suppression of
the phosphorylation of S6K. Knocking down of SIK2 by
siRNA recovered the phosphorylation of S6K. In sum-
mary, our project will provide novel insight into the
tumor suppression function of B55gamma in the regu-
lation of glucose metabolism in Glioma cells. Our study
will benefit the development of therapeutic strategies for
targeting this gene to treat human brain tumor patients.
Materials and methods
Cell culture and antibodies
Human glioma cell lines U251, U138, LN229 and Normal
human astrocyte (NHA) were purchased from American
Type Culture Collection (ATCC). Cells were grown adher-
ently in DMEM media supplemented with 10% fetal bo-
vine serum (FBS; Sigma-Aldrich Chemical Company) and1% penicillin-streptomycin (GIBCO BRL, Grand Island,
NY) and maintained in a humidified incubator containing
5% CO2 at 37°C. Cells were maintained in these culture
conditions for all experiments.
Antibodies used from this project were purchased
from: B55Gamma (Santa Cruz: sc-100417); mTOR
pathway and substrate antibody sampler kit (Cell Sig-
naling #9862&#9964); β-actin (Cell Signaling #4967);
SIK2 (Cell Signaling #6919); GLUT1 (Santa Cruz: sc-
7903); HKII (Santa Cruz: sc-130358) and LDHA (Cell
signaling #2012).Immunoprecipitation
Immunoprecipitation was conducted from cells lysed
in RIPA buffer. Equal amounts of total protein were
used for IP or IB. Clarified lysates (250 μg) were incu-
bated with primary antibody and control IgG for over-
night at 4°C cold room. After 2 h of incubation with
agarose G plus beads, beads were washed and eluted
then the elution were subjected to 10% SDS PAGE gel
electrophoreses.Plasmid DNA and siRNA transfections
The specific siRNA to SIK2 and Control siRNA were pur-
chased from Santa Cruz (sc-44364). Vector containing GFP-
tagged ORF clone of Homo sapiens protein B55gamma,
WT S6K or KA S6K were purchased from Origene. Cells
were transfected for 4 hrs with 50 nM siRNA or control
siRNA using Oligofectamine (Invitrogen, Carlsbad, CA,
USA) according to manufacturer’s instructions. The over-
expression vector containing wild-type B55gamma (2 μg),
wild-type S6K (2 μg), kinase active S6K (2 μg) or control
vector (2 μg) were transfected using Oligofectamine
(Invitrogen, Carlsbad, CA, USA) according to manufac-
turer’s instructions. After transfection cells were cultured
in complete medium for an additional 48 h in complete
medium, and then they were processed for further analysis.Protein stability assay
Cells were treated with or without CHX at 100 ug/ml or
MG-132 at 5 uM and collected at indicated time points.
Cell lysates were collected for western blot analysis
probed with anti-SIK2 antibody.Cell viability assay
A total of 5 × 104 ~ 1 × 105 cells/well were seeded in 6-well
plates. Twenty-four hours later, the medium was replaced
with fresh medium with or without glucose and incubated
for 12, 24, 36 or 48 hrs, respectively. Cell viability was de-
termined by Typan Blue staining and direct cell counting
using hematocytometer.
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Cells were seeded in 12-well plates at 1 × 105 to 3 × 105
cells per well. Culture media was collected at 48 hours
and stored at −20 degree until assayed. Glucose uptake
was measured using an Amplex Red Glucose/Glucose
Oxidase assay kit (Molecular Probes). Absorbance was
measured at 563 nm using a SpectraMax M5 plate reader
(Molecular Devices) and the results were normalized to
the amount of total protein compared with the control
cells. Lactate production in the medium was detected by
using a Lactate assay kit (BioVision). Results were nor-
malized to the amount of total protein compared with
the control cells.
Western blot analysis
Cells or homogenized cortical tissue samples were pre-
pared in NP-40 lysis buffer (150 mM NaCl, 50 mM
Tris–HCl, 1% NP-40 for cell culture; 50 mM Tris, 1 mM
EDTA, 5 mM MgCl2, 1% Triton X-100 for brain tissue)
containing protease and phosphatase inhibitors (Roche
Diagnostics GmbH) and resolved in 10 or 12% SDS gels.
Proteins were transferred onto nitrocellulose membranes
(Bio-Rad) and incubated with primary antibodies followed
by incubation with horseradish peroxidase-conjugated sec-
ondary antibodies (GE Healthcare). The immunoreactivity
was detected with an Immobilon Western Chemilumines-
cent HRP Substrate (Millipore).
Statistical data analysis
All data were analysed using GraphPad Prism 5.04. The
unpaired Student's t-test was used for the data analysis.
All data were shown as mean ± standard error (SE). A
statistical difference of P < 0.05 was considered significant.
Results
Overexpression of B55gamma suppresses glucose
metabolism in Glioma cells
Since B55gamma has been reported as a putative tumor
suppressor gene by Bluemn EG et al. [9], we raised inter-
ests in the exploration of whether B55gamma regulates
glucose metabolism in cancer cells. We stably transfected
plasmid containing wild type B55gamma into multiple
Glioma cell lines which express low levels of B55gamma
originally and specifically knocked down B55gamma ex-
pression by siRNA in NHA cells which express relative
higher level of B55gamma (Figure 1A). We next measured
the glucose uptake and lactate product in B55gamma
overexpressed cells compared with control cells. As we ex-
pected, overexpression of B55gamma in Glioma cells sig-
nificantly inhibited glucose uptake and lactate product
while knockdown of B55gamma in NHA cells increased
glucose metabolism (Figure 2B & 2C). Consistent with
our results, the major enzymes involved in the glucose
metabolism were significantly down regulated in LN229B55gamma cells and upregulated in NHA B55gamma
knocking down cells (Figure 1D). Taken together, our
data revealed that B55gamma plays an essential role in
the inhibition of glucose metabolism in Glioma cells.Glioma cells with higher amount of B55gamma exhibit
survival advantages in glucose starvation
We next examined whether the alteration of glucose me-
tabolism regulated by B55gamma contributes to the tol-
eration glucose starvation. Overexpression of B55gamma
in U251 Glioma cells significantly increased the cell viabil-
ity in response to glucose depletion in multiple time points
compared with U251 control cells, while knocking down of
B55gamma in NHA cells rendered cells sensitive to glucose
depletion (Figure 2A & 2B), suggesting B55gamma par-
ticipated in the regulation of cell apoptosis pathway in
response to glucose starvation.Overexpression of B55gamma in Glioma cells inhibits S6K
phosphorylation
To understand the mechanisms how B55gamma regulated
cell viability, we screened multiple cell survival/proliferation
pathways. Among them, we found overexpression of
B55gamma significantly decreased the phosphorylation of
S6K, but phosphorylation of 4EBP1 which was another
substrate of mTOR complex1 did not change (Figure 3A).
The phosphorylation of mTOR and upstream signaling-
phosphorylation of AKT did not change (Figure 3A), indi-
cating S6K might be a downstream target of B55gamma.
To further strengthen our results, we performed experi-
ments to check whether the B55gamma-overeexpressed
phenotype can be rescued by overexpression of wild-type
S6K or kinas active S6K. Our data showed U251B55gamma
cells displayed more resistance to Rapamycin at different
concentrations compared with U251V cells. However,
restoration of S6K by transfection of wild-type S6K or kin-
ase active S6K into B55gamma overexpressing cells re-
sensitized U251B55gamma cells to Rapamycin (Figure 3B),
revealing the B55gamma-mediated resistance to rapamy-
cin and glucose depletion might be through the suppres-
sion of S6K phosphorylation. Since we hypothesized that
the B55gamma-mediated inhibition of S6K activity con-
tributed to the tolerance to glucose depletion in Glioma
cells, we next tried to figure out whether exogenously
expression of S6K in Glioma cell can potentially reverse
the resistance to glucose depletion in U251B55gamma
cells. Under glucose depletion, overexpression of S6K
WT or S6K KA in U251B55gamma cells significantly
decreased the cell viabilities (Figure 3C), suggesting the
reduced activity of S6K might be the mechanism for
the B55gamma-mediated tolerance to glucose starvation
conditions.
Figure 1 B55gamma suppresses glucose metabolisms in Glioma cells. A. Overexpression and knockdown of PPP2R2C encoded protein-B55gamma
in U251, U138, LN229 and NHA cells. Western blot were performed with an anti-B55gamma antibody of total cell extract. β-Actin was a loading control.
B. The over-expression of B55gamma inhibited glucose uptake in U251B55gamma, LN229B55gamma, U138B55gamma cells and knockdown of
B55gamma in NHA cells increased glucose uptake compared with control cells. C. The overexpression of B55gamma inhibited lactate product
in U251B55gamma, LN229B55gamma, U138B55gamma cells and knockdown of B55gamma in NHA cells increased lactate product compared
with control cells. D. Overexpression of B55Gamma in LN229 cells upregulated major enzymes in glucose metabolism: Glut1, HKII, and LDHA.
Knockdown of B55gamma in NHA cells downregulated Glut1, HKII and LDHA expression. Western blot were performed with an anti-Glut1, anti-HKII
and anti-LDHA antibodies of total cell extract. β-Actin was a loading control. Columns, mean of three independent experiments; bars, SE. **, P < 0.01.
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of SIK2
To figure out the mechanism how B55gamma regulated
the dephosphorylation of S6K, we performed immuno-
precipitation analysis. From the multiple putative binding
partners of B55gamma, we focused on the Salt-Induced
Kinase 2 (SIK2) which specifically binds with B55gamma
in both U251gamma and U138B55gamma cells (Figure 4A).
It was interesting that the expression levels of SIK2 were
upregulated in B55gamma-overexpressing cells (Figure 4B)
which pushed us forward to explore the mechanisms how
B55gamma upregulated SIK2. We treated U251V and
U251B55gamma cells with Cycloheximide (CHX), which
inhibits protein translation in eukaryotes. Our results
showed the SIK2 expression were significantly decreased
when we inhibited the SIK2 protein synthesis in U251V
and U138V cells. However, the SIK2 levels did not de-
crease in B55gamma-overexpressing cells (Figure 4C
left), indicating when the protein synthesis was inhib-
ited, B55gamma increased the stability of SIK2 to preventdegradation. In addition, our data showed the protein
levels of SIK2 did not change by the treatments of MG-
132 which is an inhibitor of protein degradation at 0, 2,
4 and 8 hours in both control cells and B55gamma
overexpressing cells (Figure 4C right). Combined with
the CHX experiments, these data showed B55gamma
interacted with SIK2 and upregulated SIK2 expression
level through the enhancement of protein stability.
SIK2 is required in the B55gamma-mediated suppression
of S6K phosphorylation
We finally examined whether the association of B55gamma
and SIK2 is involved in the event of the deposphorylation
of S6K by B55gamma. Our data showed knocking down of
SIK2 significantly recovered the phosphorylation of S6K in
U251B55gamma and U138B55gamma cells (Figure 5A)
and the phosphorylation of 4EBP1 did not change, indicat-
ing B55gamma inhibited phosphorylation of S6K through
the interaction of SIK2. We next checked the sensibil-
ities of B55gamma overexpressing cells under glucose
Figure 2 Glioma cells with overexpression of B55gamma are insensitive to glucose starvation. A. Overexpression of B55gamma in U87,
U135 and U118 glioma cells. Glucose withdrawal induced cell death in U251V cells but U251B55gamma cells were insensitive to glucose withdrawal.
Cells were starved of glucose for 12 h, 24 h, 36 h and 48 h and cell viability assay were performed by direct counting of Trypan blue negative cells.
B. Cell death and morphological changes in U251V and U251B55gamma cells in response to glucose starvation for 12 hrs and 48 hrs. Columns, mean
of three independent experiments; bars, SE. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Figure 3 Overexpression of B55gamma in Glioma cells inhibits the phosphorylation of S6K. A. Overexpression of B55gamma in U251
decreases phosphorylation of S6K, but phosphorylation of 4EBP1 and mTOR and AKT have no significant change. B. U251 cells were transfected
with control vector or B55gamma alone or B55gamma + S6K WT or B55gamma + S6K KA for 48 hrs. Cell viability assays were performed under the
treatments of Rapamycin at 15 nM and 50 nM, DMSO treatment was control. C. Transfection of S6K WT and S6K KA into U251V and U251B55gamma
cells followed by the measurements of cell viabilities under the glucose withdrawal for 24 hrs. Columns, mean of three independent experiments; bars,
SE. **, P < 0.01; ***, P < 0.001.
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Figure 4 B55gamma binds with SIK2 and increases protein stability of SIK2. A. B55gamma interacts with SIK2 in Glioma cells. Co-Immunoprecipitation
was performed using B55gamma antibody and mouse IgG as control. Immunoblotting with SIK2 antibody showed B55gamma associated with SIK2. β-Actin
expression in 5% whole cell lysates were showed as loading controls. B. Overexpression of B55gamma in U251 and U138 cells upregulated SIK expression.
Western blot were performed with an anti-SIK2 and anti-B55gamma antibodies of total cell extract. β-Actin was a loading control. C. U251V
and U251B55gamma (upper) cells were treated with CHX at 100 ug/ml or MG-132 at 5 uM for 0, 2, 4 and 8 hrs followed by Western blotting
assay to exam the protein expression level of SIK2. U138V and U138B55gamma (lower) were treated with CHX at 100 ug/ml or MG-132 at 5
uM for 0, 2, 4 and 8 hrs followed by Western blotting assay to exam the protein expression level of SIK2.
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knocking down of SIK2 in U251B55gamma cells signifi-
cantly re-sensitized cells to glucose depletion in both
U251B55gamma and U138B55gamma cells (Figure 5B),
revealing that the association between B55gamma and
SIK2 was required for the tolerance of glucose starvation.
Discussions
As we discussed above, PPP2R2C encodes a gamma iso-
form of the B regulatory subunit subfamily-B55 gamma
among the four unrelated B subunit families. Currently,
the precise functions of B55gamma are still unclear. It
has been reported that B55gamma had a unique expres-
sion pattern in mouse brain which suggested it correlated
to intellectual disability [20]. Another study reported that
B55gamma was an inhibitor of c-Jun NH2-terminal kinase
(JNK) activation by UV irradiation through the association
with c-SRC [7]. A recent paper reported the loss of
B55gamma promotes androgen ligand depletion-resistant
prostate cancer growth, which was independent of AR-
mediated transcriptional programs indicating B55gamma
might be a tumor suppressor gene [8]. In this project,
we reported overexpression of B55gamma in gliomacells suppressed the phosphorylation of S6K, indicat-
ing B55gamma might be a putative tumor suppressor
gene.
The metabolic properties of cancer cells are different
from those of normal cells. Cancer cells are more
dependent on aerobic glycolysis, fatty acid synthesis
and glutaminolysis for proliferation [10]. Multiple on-
cogenes or tumor suppressors can regulate cancer cells
glucose metabolism. Recently, P53 has been reported to
regulate aerobic respiration at the glycolytic and oxidative
phosphorylation (OXPHOS) steps via transcriptional regu-
lation of its downstream genes [13]. Since B55gamma is a
potential tumor suppressor gene, whether B55gamma
participates in the regulatory pathway of glucose me-
tabolism or not triggered us to establish this project.
In this study, we reported a novel function of B55gamma
in the regulation of glucose metabolism in Glioma
cells. We stably transfected B55gamma in Glioma cells
and noticed that B55gamma suppressed the cancer cell
glucose uptake and lactate product. Our data demon-
strated under glucose starvation, exogenous overex-
pression of B55gamma rendered Glioma cells adaptive
to glucose starvation compared with control cells.
Figure 5 Knockdown of SIK in B55gamma overexpression cells recovers the phosphorylation of S6K. A. U251V, U251B55gamma, U138V
and U138B55gamma cells were transfected with scramble siRNA (Ctr) or SIK2 siRNA. 48 hrs after siRNA transfection, cell lysates were prepared and
Western blotting was performed to detect the phosphorylation of S6K statues. The β-actin protein was used as a loading control. B. U251B55gamma
(left) and U138B55gamma (right) cells were transfected with scramble siRNA (Ctr) or SIK2 siRNA. 48 hrs after siRNA transfection, cell were plated into
6-well plate for overnight, then the regular medium was replaced by glucose free medium for 36 h-starvation followed by the cell viability
assay. Columns, mean of three independent experiments; bars, SE. *, P < 0.05.
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S6K through the association with SIK2. It is interesting
since SIK2 belongs to the AMPK family and the function
of SIK2 has not been deeply elucidated. As well-studied,
AMPK is a central metabolic switch found in all eukaryotes
that governs glucose and lipid metabolism in response to
alterations in nutrients and intracellular energy levels. It
has been reported under nutrition starvation, AMPK was
activated to suppress mTOR-dependent transcriptional
regulators to keep tumor cell survival [21]. A recent study
described a putative mechanism for the B55gamma-
mediated de-phosphorylation of S6K by PP2A [22].
From their results, B55gamma does not bind with S6K,
but promotes the formation of the PP2A complex with
the PP2A-C subunit to further enhance the binding of
the catalytic subunit of PP2A with S6K. Their data re-
vealed that B55gamma down-regulates the S6K pathway
might through the PP2A-S6K interaction, but not the
PP2A-mTOR interaction, providing a mechanism for the
dephosphorylation of S6K by overexpression of B55gamma.
Moreover, they did not show any change on the activity of
4EBP1 by overexpression of B55gamma, the similar results
as us. Thus, both of these two studies showed a consistentlyregulatory relationship between B55gamma and S6K,
but not 4EBP1, indicating B55gamma indirectly targeting
on S6K which is a downstream effector of mTOR, but not
mTOR itself. Our data showed B55gamma associates with
and stabilizes SIK2 which was indispensably participated
in the inhibition of S6K-dependent growth regulation
to keep tumor cell survival under glucose depletion.
However, the detailed mechanisms still need further in-
vestigation. We are constructing antibodies which specific
recognize phosphorylation statues of SIK2 since there is
no commercial phosphor-SIK2 antibody available. Our
next project will focus on how B55gamma regulates
SIK2 through the association and how to target B55gamma-
SIK2-S6K pathway to develop therapeutic strategies for the
treatment of human brain tumor patients.
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